Correction to: Drug delivery systems based on hydroxyethyl starch (Bioconjugate Chemistry (2017) 28:6 (1611-1624) DOI: 10.1021/acs.bioconjchem.7b00186);Drug Delivery Systems Based on Hydroxyethyl Starch

Bioconjugate Chemistry

Volumn 28, Issue 6, 2017, Pages 1611-1624

  Paleos, Constantinos M ^a,b   Sideratou, Zili ^a   Tsiourvas, Dimitris ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b Regulon AE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CONTROLLED DRUG DELIVERY; HYDROGELS; NANOCAPSULES; PROTEINS; TARGETED DRUG DELIVERY;

ANTI-CANCER THERAPEUTICS; ANTICANCER MOLECULES; BIOCONJUGATES; BIOLOGICAL PROPERTIES; DRUG-DELIVERY SYSTEMS; HYDROXYETHYL STARCHES; ONE-STEP REACTIONS; REACTION SCHEMES; RESEARCH INTERESTS; THERAPEUTIC PROTEIN;

STARCH;

10 HYDROXYCAMPTOTHECIN; ANAKINRA; ANTINEOPLASTIC AGENT; DOXORUBICIN; ERYTHROPOIETIN; FLUOROURACIL; HETASTARCH; METHOTREXATE; NANOCAPSULE; HETASTARCH DERIVATIVE;

COVALENT BOND; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PROTEIN BINDING; HUMAN; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PLASMA HALF LIFE; REVIEW; CHEMISTRY; PROCEDURES;

DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; HYDROXYETHYL STARCH DERIVATIVES; NANOCAPSULES;

EID: 85021099015     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.7b00400     Document Type: Erratum

References (53)

1. Bangham, A. D., Standish, M. M., and Watkins, J. C. (1965) Diffusion of univalent ions across lamellae of swollen phospholipids J. Mol. Biol. 13, 238-252 10.1016/S0022-2836(65)80093-6
2. Ringsdorf, H. (1975) Structure and properties of pharmacologically active polymers J. Polym. Sci., Polym. Symp. 51, 135-153 10.1002/polc.5070510111
3. Liu, Z., Jiao, Y., Wang, Y., Zhou, C., and Zhang, Z. (2008) Polysaccharides-based nanoparticles as drug delivery systems Adv. Drug Delivery Rev. 60, 1650-1662 10.1016/j.addr.2008.09.001
4. Zhang, N., Wardwell, P. R., and Bader, R. A. (2013) Polysaccharide-based micelles for drug delivery Pharmaceutics 5, 329-352 10.3390/pharmaceutics5020329
5. Marchessault, R. H., Ravenelle, F., and Zhu, X. X. (2006) Polysaccharides for Drug Delivery and Pharmaceutical Applications. In ACS Symposium Series, p 57, Chapter 3, Vol 934, American Chemical Society, Washington, DC.
6. Debele, T. A., Mekuria, S. L., and Tsai, H.-C. (2016) Polysaccharide based nanogels in the drug delivery system: Application as the carrier of pharmaceutical agents Mater. Sci. Eng., C 68, 964-981 10.1016/j.msec.2016.05.121
7. Boldt, J. (2009) Modern degradable hydroxyethyl starches: current concepts Anesth. Analg. 108, 1574-1582 10.1213/ane.0b013e31819e9e6c
8. Besheer, A., Hause, G., Kressler, J., and Mäder, K. (2007) Hydrophobically modified hydroxyethyl starch: Synthesis, characterization, and aqueous self-assembly into nano-sized polymeric micelles and vesicles Biomacromolecules 8, 359-367 10.1021/bm0609487
9. Narayanan, D., Nair, S., and Menon, D. (2015) A systematic evaluation of hydroxyethyl starch as a potential nanocarrier for parenteral drug delivery Int. J. Biol. Macromol. 74, 575-584 10.1016/j.ijbiomac.2014.12.012
10. Dellacherie, E. (1996) Polysaccharides in medical applications, pp 525-544, Marcel Dekker, Inc., New York, NY.
11. Kozek-Langenecker, S. A. (2005) Effects of hydroxyethyl starch solutions on hemostasis Anesthesiology 103, 654-660 10.1097/00000542-200509000-00031
12. Noga, M., Edinger, D., Kläger, R., Wegner, V. S., Spatz, J. P., Wagner, E., Winter, G., and Besheer, A. (2013) The effect of molar mass and degree of hydroxymethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes Biomaterials 34, 2530-2538 10.1016/j.biomaterials.2012.12.025
13. Schortgen, F., Deye, N., and Brochard, L. (2004) Preferred plasma volume expanders for critically ill patients: results of an international survey Intensive Care Med. 30, 2222-2229 10.1007/s00134-004-2415-1
14. Zarychanski, R., Abou-Setta, A. M., Turgeon, A. F., Houston, B. L., McIntyre, L., Marshall, J. C., and Fergusson, D. A. (2013) Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation. A systematic review and meta-analysis JAMA 309, 678-688 10.1001/jama.2013.430
15. Paleos, C. M., Sideratou, Z., Theodossiou, T. A., and Tsiourvas, D. (2015) Carboxylated hydroxyethyl starch: A novel Polysaccharide for the delivery of doxorubicin Chem. Biol. Drug Des. 85, 653-658 10.1111/cbdd.12447
16. Mohan, P. and Rapoport, N. (2010) Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking Mol. Pharmaceutics 7, 1959-1973 10.1021/mp100269f
17. Paleos, C. M., Tsiourvas, D., Sideratou, Z., and Tziveleka, L.-A. (2010) Drug delivery employing multifunctional dendrimers and hyperbranched polymers Expert Opin. Drug Delivery 7, 1387-1398 10.1517/17425247.2010.534981
18. Laginha, K. M., Venwoert, S., Charrois, G. J., and Allen, T. M. (2005) Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors Clin. Cancer Res. 11, 6944-6949 10.1158/1078-0432.CCR-05-0343
19. Zhu, Y., Yao, X., Chen, X., and Chen, L. (2015) pH-sensitive hydroxyethyl starch-doxorubicin conjugates as antitumor prodrugs with enhanced anticancer efficacy J. Appl. Polym. Sci. 132, 1 10.1002/app.42778
20. Hu, H., Li, Y., Zhou, Q., Ao, Y., Yu, C., Wan, Y., Xu, H., Li, Z., and Yang, X. (2016) Redox-sensitive hydroxyethyl starch-doxorubicin conjugate for tumor targeted drug delivery ACS Appl. Mater. Interfaces 8, 30833-30844 10.1021/acsami.6b11932
21. Li, G., Li, Y., Tang, Y., Zhang, Y., Zhang, Y., Yin, T., Xu, H., Cai, C., and Tang, X. (2014) Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydrroxy camptothecin Int. J. Pharm. 471, 234-244 10.1016/j.ijpharm.2014.05.038
22. Zhang, L., Yang, M., Wang, Q., Li, Y., Guo, R., Jiang, X., Yang, C., and Liu, B. (2007) 10-Hydroxycamptothecin loaded nanoparticles: Preparation and antitumor activity in mice J. Controlled Release 119, 153-162 10.1016/j.jconrel.2007.02.013
23. Brockman, R. and Anderson, E. (1963) Biochemistry of cancer (metabolic aspects) Annu. Rev. Biochem. 32, 463-512 10.1146/annurev.bi.32.070163.002335
24. Luo, Q., Wang, P., Miao, Y., He, H., and Tang, X. (2012) A novel 5-fluorouracil prodrug using hydroxyethyl starch as a macromolecular carrier for sustained release Carbohydr. Polym. 87, 2642-4647 10.1016/j.carbpol.2011.11.039
25. Goszczyński, T. M., Filip-Psurska, B., Kempińska, K., Wietrzyk, J., and Boratyński (2014) Hydroxyethyl starch as an effective methotrexate carrier in anticancer therapy Pharmacol. Res. Perspect. 2, e00047 10.1002/prp2.47
26. Nevozhay, D., Budzynska, R., Kanska, U., Jagiello, M., Omar, M. S., Boratynski, J., and Opolski, A. (2006) Antitumor properties and toxicity of dextran-methotrexate conjugates are dependent on the molecular weight of the carrier Anticancer Res. 26, 1135-1143
27. Torchilin, V. (2011) Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Delivery Rev. 63, 131-135 10.1016/j.addr.2010.03.011
28. Pisal, D. S., Kosloski, M. P., and Balu-lyer, S. V. (2010) Delivery of therapeutic proteins J. Pharm. Sci. 99, 2557-2575 10.1002/jps.22054
29. Rehman, K., Hamid Akash, M. S., Akhtar, B., Tariq, M., Mahmood, A., and Ibrahim, M. (2016) Delivery of therapeutic proteins: Challenges and Strategies Curr. Drug Targets 17, 1172-1188 10.2174/1389450117666151209120139
30. Besheer, A., Liebner, R., Meyer, M., and Winter, G. (2013) Challenges for PEGylated proteins and alternative half-life extension technologies based on biodegradable polymers. In ACS Symposium Series, Chapter 13, ACS Washington, Washington DC.
31. Kontermann, R. E. (2011) Strategies for extended serum half-life of protein therapeutics Curr. Opin. Biotechnol. 22, 868-876 10.1016/j.copbio.2011.06.012
32. Hey, T., Knoller, H., and Vorstheim, P. (2012) Therapeutic Proteins: Strategies to Modulate Their Plasma Half-Lives, Wiley-VCH, Weinheim, Germany.
33. Abuchowski, A., van Es, T., Palczuk, N. C., and Davis, F. F. (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol J. Biol. Chem. 252, 3578-3581
34. Pasut, G. (2014) Polymers for Protein Conjugation Polymers 6, 160-178 10.3390/polym6010160
35. Styslinger, T. J., Zhang, N., Bhatt, V. S., Pettit, N., Palmer, A. F., and Wang, P. G. (2012) Site-selective glycosylation of Hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation J. Am. Chem. Soc. 134, 7507-7515 10.1021/ja300893t
36. Gregoriadis, G., Jain, S., Papaioannou, I., and Laing, P. (2005) Improving the therapeutic efficiency of peptides and proteins: A role for polysialic acids Int. J. Pharm. 300, 125-130 10.1016/j.ijpharm.2005.06.007
37. Salmaso, S. and Caliceti, P. (2013) Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers J. Drug Delivery 2013, 1 10.1155/2013/374252
38. Amoozgar, Z. and Yeo, Y. (2012) Recent advances in stealth coating of nanoparticle drug delivery systems WIREs Nanomed Nanobiotechnol 4, 219-233 10.1002/wnan.1157
39. Pelegri-O'Day, E. M., Lin, E.-W., and Maynard, H. D. (2014) Therapeutic protein-polymer conjugates: Advancing beyond PEGylation J. Am. Chem. Soc. 136, 14323-14332 10.1021/ja504390x
40. Liebner, R., Mathaes, R., Meyer, M., Hey, T., Winter, G., and Besheer, A. (2014) Protein HESylation for half-life extension: synthesis, characterization and pharmacokinetics of HESylated anakinra Eur. J. Pharm. Biopharm. 87, 378-385 10.1016/j.ejpb.2014.03.010
41. Burger, D. and Dayer, J. M. (2012) IL-1Ra. In Cytokine Reference (Oppenheim, J. J. and Feldmann, M., Eds.) pp 319-336, Academic Press, London, England.
42. Liebner, R., Meyer, M., Hey, T., Winter, G., and Besheer, A. (2015) Head to head comparison of the formulation and stability of concentrated solutions of HESylated versus PEGylated anakinra J. Pharm. Sci. 104, 515-526 10.1002/jps.24253
43. Baier, G., Baumann, D., Siebert, J. M., Musyanovych, A., Mailänder, V., and Landfester, K. (2012) Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules Biomacromolecules 13, 2704-2715 10.1021/bm300653v
44. Freichels, H., Wagner, M., Okwieka, P., Meyer, R. G., Mailänder, V., Landfester, K., and Musyanovych, A. (2013) (Oligo)mannose functionalized hydroxyethyl starch nanocapsules: en route to drug delivery systems with targeting properties J. Mater. Chem. B 1, 4338-4348 10.1039/c3tb20138d
45. Schwoerer, A. D. A., Harling, S., Scheibe, K., Menzel, H., and Daniels, R. (2009) Influence of degree of substitution of HES-HEMA on the release of incorporated drug models from corresponding hydrogels Eur. J. Pharm. Biopharm. 73, 351-356 10.1016/j.ejpb.2009.08.003
46. Harling, S., Schwoerer, A., Scheibe, K., Daniels, R., and Menzel, H. (2010) A new hydrogel drug delivery system based on hydroxyethyl starch derivatives J. Microencapsulation 27, 400-408 10.3109/02652040903367301
47. Schwoerer, A., Harling, S., Menzel, H., and Daniels, R. (2008) Release behavior of hydrogel microparticles based on hydroxyl-ethyl-starch as a drug delivery system for proteins J. Controlled Release 132, e16-e17 10.1016/j.jconrel.2008.09.050
48. Stanzl, E. G., Trantow, B. M., Vargas, J. R., and Wender, P. A. (2013) Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications Acc. Chem. Res. 46, 2944-2954 10.1021/ar4000554
49. Coburn, J. M. and Kaplan, D. L. (2015) Engineering Biomaterial-Drug Conjugates for local and sustained chemotherapeutic delivery Bioconjugate Chem. 26, 1212-1223 10.1021/acs.bioconjchem.5b00046
50. Buwalda, S. J., Vermonden, T., and Hennink, W. E. (2017) Hydrogels for therapeutic delivery: Current developments and future directions Biomacromolecules 18, 316 10.1021/acs.biomac.6b01604
51. Paleos, C. M., Tsiourvas, D., and Sideratou, Z. (2016) Triphenylphosphonium Decorated Liposomes and Dendritic Polymers: Prospective Second Generation Drug Delivery Systems for Targeting Mitochondria Mol. Pharmaceutics 13, 2233-2241 10.1021/acs.molpharmaceut.6b00237
52. Maity, A. R. and Stepensky, D. (2016) Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems Mol. Pharmaceutics 13, 1-7 10.1021/acs.molpharmaceut.5b00697
53. Sharma, A. R., Kundu, S. K., Nam, J.-S., Sharma, G., Doss, C. G. P., Lee, S.-S., and Chakraborty, C. (2014) Next Generation Delivery System for Proteins and Genes of Therapeutic Purpose: Why and How? BioMed Res. Int. 2014, 1 10.1155/2014/327950